Insulin-like growth factor

DBCAT005263Pharmacologic class

Peptides that include INSULIN-LIKE GROWTH FACTOR 1 (IGF1), and IGF2. They influence brain development through their effects on CELL PROLIFERATION; CELL SURVIVAL; and NEUROGENESIS. A DrugBank category of 3 drugs. 1 of them is approved.

Drugs: Insulin-like growth factor II
Mecasermin
Tralesinidase alfa

What you can answer from here — as of January 28, 2021

3DrugsEach linked to its full drug card

Listed above

6Drug targetsEvery drug–target pair in the class, with bond type

9Marketed productsAcross the regions we cover, with dosage forms and routes

3Routes of administrationHow the drugs in this class are given

Which targets do Insulin-like growth factor share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account